OptMed, Inc. (OMED)
|Net Income (ttm)||-3.86M|
OptMed is a clinical-stage medical device company focused on the development and commercialization of novel surgical adhesives for the localized treatment of patients with external and internal wounds. Our proprietary technology platform is based on a chemistry called methylidene malonate (“MM212”), a biocompatible polymer originally designed for drug delivery which has been extensively tested for biocompatibility and adhesive properties in topical and internal applications. MM212-based surgical adhesives have unique versatile properties wh... [Read more...]
Financial PerformanceFinancial Statements
OptMed, which is commercializing topical tissue adhesives used in surgery, filed on Wednesday with the SEC to raise up to $23 million in an initial public offering.
OptMed} has filed to go public with an IPO on the NASDAQ.